MorphoSys has a proven track record of successful alliances. Through its drug discovery partnerships with leading pharmaceutical companies, MorphoSys has created one of the broadest therapeutic antibody pipelines in the industry. The Company is continuously expanding its product pipeline by adding new partnered programs, and by building a portfolio of fully-owned therapeutic antibodies and co-development programs. Via its business unit AbD Serotec, MorphoSys provides superior antibodies for diagnostic and research applications. Custom requirements for antibody development can also be met through a range of techniques and applications.
